Bioactivity of American ginseng by knockout extract preparation using monoclonal antibody

Current Drug Discovery Technologies

Volumn 8, Issue 1, 2011, Pages 32-41

  Yuan, Chun Su ^a   Tanaka, Hiroyuki ^b  

^a UNIVERSITY OF CHICAGO   (United States)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

American ginseng berry; Ginsenoside Re; Knockout extract; Monoclonal antibody

Indexed keywords

AMERICAN GINSENG BERRY EXTRACT; ANTIDIABETIC AGENT; ANTIOBESITY AGENT; GINSENOSIDE RE; GINSENOSIDE RE KNOCK OUT AMERICAN GINSENG BERRY EXTRACT; GINSENOSIDE RE MONOCLONAL ANTIBODY; GLUCOSE; MONOCLONAL ANTIBODY; PLANT EXTRACT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BERRY; C57BL 6 MOUSE; CONTROLLED STUDY; DOSE RESPONSE; DRUG ACTIVITY; DRUG EFFECT; EXPERIMENTAL DIABETES MELLITUS; FLOWER; GENE EXPRESSION; GINSENG; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RECEPTOR UPREGULATION; TREATMENT DURATION;

ANIMALS; ANTIBODIES, MONOCLONAL; BLOOD GLUCOSE; BODY WEIGHT; DIABETES MELLITUS, TYPE 2; FRUIT; GENE EXPRESSION; GINSENOSIDES; GLUCOSE TOLERANCE TEST; HYPOGLYCEMIC AGENTS; INJECTIONS, INTRAPERITONEAL; MALE; MICE; MICE, INBRED C57BL; MICE, OBESE; OBESITY; PANAX; PHYTOTHERAPY; PLANT EXTRACTS;

EID: 79951690982     PISSN: 15701638     EISSN: None     Source Type: Journal    
DOI: 10.2174/157016311794519992     Document Type: Article

References (52)

1. Diabetes Vital Statistics, American Diabetes Association. Alexandria, VA, 1996.
2. Diabetes Research Working Group, Conquering Diabetes-A Strategic Plan for the 21st Century, 1999.
3. Liu QZ, Pettitt DJ, Hanson RL, et al. Glycated haemoglobin, plasma glucose and diabetic retinopathy: cross-sectional and prospective analyses. Diabetologia 1993;36:428-32. (Pubitemid 23124047)
4. Klein R, Klein BE, Moss SE, Cruickshanks KJ. Relationship of hyperglycemia to the long-term incidence and progression of diabetic retinopathy. Arch Intern Med 1994;154:2169-78. (Pubitemid 24317263)
5. Abraira C, Colwell JA, Nuttall FQ, et al. Veterans affairs cooperative study on glycemic control and complications in type II diabetes (VA CSDM). Results of the feasibility trial. Veterans affairs cooperative study in type II diabetes. Diabetes Care 1995;18:1113-23.
6. Ohkubo Y, Kishikawa H, Araki E, et al. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Res Clin Pract 1995;28:103-17.
7. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-86.
8. DeFronzo RA. Pharmacologic therapy for type 2 diabetes mellitus. Ann Intern Med 1999;131:281-303. (Pubitemid 29383658)
9. Ackerknecht EH. A short history of medicine. Baltimore, MD: Johns Hopkins University Press 1982.
10. Bensky D, Gamble A. chinese herbal medicine materia medica. Seattle, WA: Eastland Press 1993.
11. Huang KC. The pharmacology of chinese herbs. Boca Raton, FL: CRC Press, 1999.
12. Lee FC. Facts about ginseng, The elixir of life. Elizabeth, NJ: Hollyn International, 1992.
13. Attele AS, Wu JA, Yuan CS. Multiple pharmacological effects of ginseng. Biochem Pharmacol 1999;58:1685-93.
14. Kimura M. Hypoglycemic component in ginseng radix and its insulin release. In Proceedings of the 3rd International Ginseng Symposium. Seoul, Korea, Korean Ginseng Research Institute, 1980.
15. Kimura M, Waki I, Chujo T, et al. Effects of hypoglycemic components in ginseng radix on blood insulin level in alloxan diabetic mice and on insulin release from perfused rat pancreas. J Pharmacobiodyn 1981;4:410-7. (Pubitemid 11050224)
16. Kimura M, Waki I, Tanaka O, Nagai Y, Shibata S. Pharmacological sequential trials for the fractionation of components with hypoglycemic activity in alloxan diabetic mice from ginseng radix. J Pharmacobiodyn 1981;4:402-9. (Pubitemid 11050223)
17. Kimura M, Suzuki J. The pattern of action of blended Chinese traditional medicines to glucose tolerance curves in genetically diabetic KK-CAy mice. J Pharmacobiodyn 1981;4:907-15. (Pubitemid 12150913)
18. Yokozawa T, Kobayashi T, Oura H, Kawashima Y. Studies on the mechanism of the hypoglycemic activity of ginsenoside-Rb2 in streptozotocindiabetic rats. Chem Pharm Bull 1985;33:869-72. (Pubitemid 15075725)
19. Kimura I, Nakashima N, Sugihara Y, Fu-Jun. C, Kimura M. The antihyperglycemic blend effect of traditional Chinese medicine Byakko-ka-ninjin-to on alloxan and diabetic KK-CAy mice. Phytother Res 1999;13:484-8. (Pubitemid 29445765)
20. Sotaniemi EA, Haapakoski E, Rautio A. Ginseng therapy in noninsulindependent diabetic patients. Diabetes Care 1995;18:1373-5.
21. Vuksan V, Sievenpiper JL, Koo VYY, et al. American Ginseng (Panax quinquefolius L) reduces postprandial glycemia in nondiabetic subjects and subjects with type 2 diabetes mellitus. Arch Intern Med 2000;160:1009-13. (Pubitemid 30191931)
22. Xie JT, Wang CZ, Ni M, et al. American ginseng berry juice intake reduces blood glucose and body weight in ob/ob mice. J Food Sci 2007;72:590-4.
23. Dey L, Xie JT, Wang A, Wu J, Maleckar SA, Yuan CS. Antihyperglycemic effects of ginseng: comparison between root and berry. Phytomedicine 2003;10:600-5. (Pubitemid 37092688)
24. Shao ZH, Xie JT, Vanden Hoek TL, et al. Antioxidant effects of American ginseng berry extract in cardiomyocytes exposed to acute oxidant stress. Biochim Biophys Acta 2004;1670:165-71. (Pubitemid 38229767)
25. Attele AS, Zhou YP, Xie JT, et al. Antidiabetic effects of Panax ginseng berry extract and the identification of an effective component. Diabetes 2002;51:1851-8. (Pubitemid 34564298)
26. Sakata R, Shoyama Y, Murakami H. Production of monoclonal antibodies and enzyme immunoassay for typical adenylate cyclase activator, forskolin. Cytotechnology 1994;16:101-8.
27. Yanagihara H, Sakata R, Shoyama Y, Murakami H. Rapid analysis of small samples containing forskolin using monoclonal antibodies. Planta Med 1996;62:169-72. (Pubitemid 26163225)
28. Shoyama Y, Fukada T, Murakami H. Production of monoclonal antibodies and ELISA for thebaine and codeine. Cytotechnology 1996;19:55-61.
29. Tanaka H, Goto Y, Shoyama Y. Monoclonal antibody based enzyme immunoassay for marihuana (cannabinoid) compounds. J Immunoassay 1996;17:321-42. (Pubitemid 26404780)
30. Ishiyama M, Shoyama Y, Murakami H, Shinohara H. Production of monoclonal antibodies and development of an ELISA for solamargine. Cytotechnology 1996;18:153-8. (Pubitemid 3044099)
31. Morinaga O, Tanaka H, Shoyama Y. Production of monoclonal antibody against a major purgative component, sennoside A, its characterization and ELISA. Analyst 2000;125:1109-13. (Pubitemid 30392248)
32. Tanaka H, Fukuda N, Shoyama Y. Formation of monoclonal antibody against a major ginseng component, ginsenoside Rb1 and its characterization. Cytotechnology 1999;29:115-20. (Pubitemid 29205825)
33. Fukuda N, Tanaka H, Shoyama Y. Formation of monoclonal antibody against a major ginseng component, ginsenoside Rg1 and its characterization. Cytotechnology 2000;34:197-204. (Pubitemid 32235013)
34. Morinaga O, Tanaka H, Shoyama Y. Detection and quantification of ginsenoside Re in ginseng samples by chromatographic immunostaining method using monoclonal antibody against ginsenoside Re. J Chromatogr B Analyt Technol Biomed Life Sci 2006;830:100-4. (Pubitemid 41831394)
35. Wang CZ, Zhang B, Song WX, et al. Steamed American ginseng berry: ginsenoside analyses and anticancer activities. J Agric Food Chem 2006;54:9936-42. (Pubitemid 46158993)
36. Sritularak B, Morinaga O, Yuan CS, Shoyama Y, Tanaka H. Quantitative analysis of ginsenosides Rb1, Rg1, and Re in American ginseng berry and flower samples by ELISA using monoclonal antibodies. J Nat Med 2009;63:360-3.
37. Harkey MR, Henderson GL, Gershwin ME, Stern JS, Hackman RM. Variability in commercial ginseng products: an analysis of 25 preparations. Am J Clin Nutr 2001;73:1101-6. (Pubitemid 32496951)
38. Chan TWD, But PPH, Cheng SW, Kwok IMY, Lau FW, Xu HX. Differentiation and authentication of Panax ginseng, Panax quinquefolius, and ginseng products by using HPLC/MS. Anal Chem 2000;72:1281-7. (Pubitemid 30163787)
39. Luchtefeld R, Kostorys E, Smith RE. Determination of ginsenosides Rb1, Rc, and Re in different dosage forms of ginseng by negative ion electrospray liquid chromatography-mass spectrometry. J Agric Food Chem 2004;52:4953-6.
40. Yanagihara H, Sakata R, Minami H, Tanaka H, Shoyama Y, Murakami H. Immunoaffinity column chromatography against forskolin using an anti-forskolin monoclonal antibody and its application. Anal Chim Acta 1996;335(1-2): 63-70. (Pubitemid 26402909)
41. Putalun W, Tanaka H, Shoyama Y. Rapid separation of solasodine glycosides by an immunoaffinity column using anti-solamargine monoclonal antibody. Cytotechnology 1999;31(1-2): 151-6. (Pubitemid 29471580)
42. Fukuda N, Tanaka H, Shoyama Y. Applications of ELISA, Western blotting and immunoaffinity concentration for survey of ginsenosides in crude drugs of Panax species and traditional Chinese herbal medicines. Analyst 2000;125(8):1425-9. (Pubitemid 30665293)
43. Xu JS, Tanaka H, Shoyama Y. One-step immunochromatographic separation and ELISA quantification of glycyrrhizin from traditional Chinese medicines. J Chromatogr B Analyt Technol Biomed Life Sci 2007;850(1-2): 53-8. (Pubitemid 46618142)
44. Reaven GM. Insulin resistance in noninsulin-dependent diabetes mellitus. Does it exist and can it be measured? Am J Med 1983;74:3-17.
45. Genuth SM, Przybylski RJ, Rosenberg DM. Insulin resistance in genetically obese, hyperglycemic mice. Endocrinology 1971;88:1230-8.
46. DeFronzo RA, Ferrannini E. Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 1991;14:173-94.
47. Friedman JE, Dohm GL, Leggett-Frazier N, et al. Restoration of insulin responsiveness in skeletal muscle of morbidly obese patients after weight loss. Effect on muscle glucose transport and glucose transporter GLUT4. J Clin Invest 1992;89:701-5.
48. Xie JT, Mehendale SR, Li Xinmin, et al. Anti-diabetic effect of ginsenoside Re in ob/ob mice. Biochim Biophys Acta 2005;1740:319-25. (Pubitemid 40804743)
49. Huang KC. The pharmacology of Chinese herbs. Boca Raton, FL: CRC Press, 1999.
50. Dey L, Attele AS, Yuan CS. Alternative therapies for type 2 diabetes. Altern Med Rev 2002;7:45-58. (Pubitemid 34203979)
51. Attele AS, Wu JA, Yuan CS. Ginseng pharmacology: multiple constituents and multiple actions. Biochem Pharmacol 1999;58:1685-93. (Pubitemid 29505408)
52. Chen SE, Sawchuk RJ, Staba EJ. American ginseng: American ginseng: III. Pharmacokinetics of ginsenosides in the rabbit. Eur J Drug Metab Pharmacokinet 1980;5:161-8. (Pubitemid 11252888)